Your browser doesn't support javascript.
loading
Cost-utility of reduction mammaplasty assessed for the Brazilian public health system.
Araújo, Carlos Delano Mundim; Veiga, Daniela Francescato; Hochman, Bernardo Sérgio; Abla, Luiz Eduardo Felipe; Oliveira, Ana Carolina Salles; Novo, Neil Ferreira; Veiga-Filho, Joel; Ferreira, Lydia Masako.
Afiliação
  • Araújo CD; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Veiga DF; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Hochman BS; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Abla LE; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Oliveira AC; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Novo NF; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Veiga-Filho J; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
  • Ferreira LM; Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the
Aesthet Surg J ; 34(8): 1198-204, 2014 Nov.
Article em En | MEDLINE | ID: mdl-24973340
BACKGROUND: Economic evaluation is important for making decisions about resource allocation. Few cost-utility or cost-effectiveness studies on breast hypertrophy have been reported in the medical literature. OBJECTIVES: The authors sought to determine the cost-utility of reduction mammaplasty in the Brazilian national health care system. METHODS: This randomized controlled study was conducted in a university-affiliated hospital. Sixty patients with breast hypertrophy were enrolled prospectively and were assigned randomly to either the control group (n = 30 patients who received follow-up for 6 months) or the treatment group (n = 30 patients who underwent reduction mammaplasty). Direct costs were recorded, and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) was administered to both groups at the beginning of the study (preoperatively for the treatment group) and 3 and 6 months postoperatively. Utility was determined with Instrument 6D of the Brazilian version of the Short-Form Health Survey (SF-6D), from the SF-36 data. RESULTS: At the 6-month follow-up, the treatment group showed an improvement in utility, with an average direct cost of approximately £104. CONCLUSIONS: Reduction mammaplasty performed in the Brazilian national health care system provides a cost-utility ratio equivalent to approximately £142 per 1 quality-adjusted life year.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saúde Pública / Mamoplastia / Custos de Cuidados de Saúde / Análise Custo-Benefício / Programas Nacionais de Saúde Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies Aspecto: Determinantes_sociais_saude / Patient_preference Limite: Adolescent / Adult / Female / Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Aesthet Surg J Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saúde Pública / Mamoplastia / Custos de Cuidados de Saúde / Análise Custo-Benefício / Programas Nacionais de Saúde Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies Aspecto: Determinantes_sociais_saude / Patient_preference Limite: Adolescent / Adult / Female / Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Aesthet Surg J Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido